TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23632235

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation, 3 g CLA/d for 6 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo (sunflower oil) for 6 weeks
Number of subjects: 34
Study: 21590648

Group type: EXPERIMENTAL
Intervention: Pioglitazone (titrated to 45 mg/day)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Glibenclamide (titrated to 15 mg/day)
Number of subjects: 201
Study: 19225433

Group type: EXPERIMENTAL
Intervention: Lotrafilcon A (high oxygen permeability)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Etafilcon A (low oxygen permeability)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Orbscan measurements
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ultrasound measurements
Number of subjects: 20
Study: 17053155

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (1296 mg EPA + 864 mg DHA/day) for 8 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Flaxseed oil supplementation (3510 mg alpha-linolenic acid + 900 mg linoleic acid/day) for 8 weeks
Number of subjects: 20
Study: 15051770

Group type: EXPERIMENTAL
Intervention: Intrapleural bleomycin (83 patients)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Intrapleural interferon alfa-2b (IFN) (77 patients)
Number of subjects: 160
Study: 11094870

Group type: EXPERIMENTAL
Intervention: Cryotherapy and its combinations with other therapeutic physical factors
Number of subjects: 328
Study: 9278195

Group type: EXPERIMENTAL
Intervention: Neoral (5 mg kg(‐1) dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CsA capsules (5 mg kg(‐1) dose)
Number of subjects: 10
Study: 1329172

Group type: EXPERIMENTAL
Intervention: Group sequential method for determining study duration in clinical trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 3978249

Group type: COMPARATOR
Intervention: Tamoxifen (30 mg daily)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus nandrolone decanoate (100 mg i.m. once a week for four weeks, then every other week)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Tamoxifen plus nandrolone decanoate
Number of subjects: 98
Study: 3625143

Group type: EXPERIMENTAL
Intervention: Nicotine chewing gum only
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Nicotine chewing gum with extensive personal instruction
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (no desire to stop smoking)
Number of subjects: 99
Study: 30950795

Group type: EXPERIMENTAL
Intervention: The Adventures of DoReMiFa (digital game-based and school-based intervention)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 459
Study: 29275597

Group type: EXPERIMENTAL
Intervention: 40% pre-ASIR-V with 60% post-ASIR-V image reconstruction
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Subgroups B2-B10, C2-C3, D1-D2
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Subgroups B4-B10, C2-C3, D1-D2
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Subgroups B3-B8, C2-C3, D1-D2
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (40% ASIR)
Number of subjects: 160
Study: 26283753

Group type: EXPERIMENTAL
Intervention: Virtual reality simulation training (40 minutes using a haptic transvaginal simulator)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional teaching (40 minutes including a conference with slides and videos)
Number of subjects: 34
Study: 23374998

Group type: EXPERIMENTAL
Intervention: Floor Reaction Orthoses (FROs) optimised for ankle stiffness
Number of subjects: 32

Group type: COMPARATOR
Intervention: Shoes alone
Number of subjects: 32
Study: 21474675

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDM) 5 g/m² as a 24-hour infusion at weeks 4, 7, 10, and 13
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate (HDM)
Number of subjects: 436

Group type: COMPARATOR
Intervention: No high-dose methotrexate (no HDM)
Number of subjects: 436
Study: 18372169

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best supportive care (BSC)
Number of subjects: 0
Study: 16492230

Group type: EXPERIMENTAL
Intervention: Sumatriptan NS 20 mg
Number of subjects: 738

Group type: EXPERIMENTAL
Intervention: Sumatriptan NS 5 mg
Number of subjects: 738

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 738
Study: 14556671

Group type: EXPERIMENTAL
Intervention: Epoetin alfa treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed epoetin alfa treatment
Number of subjects: 0
Study: 10851920

Group type: EXPERIMENTAL
Intervention: HIV screening offered on a routine basis in antenatal care since 1987, with 96% of pregnant women screened.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HIV screening during a period of two years.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Doctors and midwives involved in antenatal care.
Number of subjects: 0
Study: 9100722

Group type: EXPERIMENTAL
Intervention: Advance directives with specific instructions to forgo life-sustaining treatment
Number of subjects: 4804

Group type: COMPARATOR
Intervention: Advance directives without specific instructions
Number of subjects: 4804
Study: 1589134

Group type: EXPERIMENTAL
Intervention: High hydration (2 lt/m2)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Low hydration (1.5 lt/m2)
Number of subjects: 2
Study: 3157396

Group type: EXPERIMENTAL
Intervention: Sufentanil 20 micrograms kg‐1, followed by 50 micrograms at 30-min intervals
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fentanyl 100 micrograms kg‐1, followed by 250 micrograms at 30-min intervals
Number of subjects: 20
Study: 31412913

Group type: EXPERIMENTAL
Intervention: Serious game 'You & I'
Number of subjects: 172

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 172
Study: 27904951

Group type: EXPERIMENTAL
Intervention: Peri-articular multimodal drug injection (bupivacaine hydrochloride, morphine sulphate, epinephrine, and ketorolac)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (epinephrine only)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Peri-articular multimodal drug injection
Number of subjects: 137
Study: 26497391

Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy (TF-CBT)
Number of subjects: 6
Study: 23414498

Group type: EXPERIMENTAL
Intervention: Brief motivational feedback (BMF)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Intake assessment as usual (AAU)
Number of subjects: 84
Study: 21928867

Group type: EXPERIMENTAL
Intervention: Treatment entry
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: During treatment
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Posttreatment
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Overall alcohol use
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Latent alcohol use growth factors
Number of subjects: 163
Study: 19330295

Group type: EXPERIMENTAL
Intervention: Concurrent radiochemotherapy (RTCT) with cisplatin 20 mg/m(2) x 5 days
Number of subjects: 566

Group type: COMPARATOR
Intervention: Radiotherapy (RT) alone
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Surgery after RT or RTCT
Number of subjects: 566

Group type: COMPARATOR
Intervention: Nonoperated patients
Number of subjects: 566
Study: 17765156

Group type: EXPERIMENTAL
Intervention: Open tension-free repair (TFR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Watchful waiting (WW)
Number of subjects: 0
Study: 15700913

Group type: EXPERIMENTAL
Intervention: Active nicotine patch
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: HRT group
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo nicotine patch
Number of subjects: 94

Group type: COMPARATOR
Intervention: Non-HRT group
Number of subjects: 94
Study: 12139546

Group type: EXPERIMENTAL
Intervention: Desflurane titrated with AAItrade mark‐index (target AAItrade mark‐index of 20+/‐5)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Desflurane titrated according to routine clinical signs (control group)
Number of subjects: 30
Study: 9579151

Group type: EXPERIMENTAL
Intervention: L-tyrosine (100 mg/kg body weight/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: L-alanine (placebo)
Number of subjects: 21
Study: 7543651

Group type: EXPERIMENTAL
Intervention: IV infusion of porcine galanin 500 micrograms in 100 mL saline
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: IV injection of GHRH (1-29)NH2 1 microgram/kg plus GnRH 100 micrograms at time 0 plus IV infusion of porcine galanin 500 micrograms in 100 mL saline from -10 to +30 minutes
Number of subjects: 13

Group type: COMPARATOR
Intervention: GHRH (1-29)NH2 1 microgram/kg plus GnRH 100 micrograms at time 0
Number of subjects: 13

Group type: COMPARATOR
Intervention: GnRH
Number of subjects: 13
Study: 2615925

Group type: EXPERIMENTAL
Intervention: 200 mg WEB 1881 FU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 600 mg WEB 1881 FU
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 350265

Group type: EXPERIMENTAL
Intervention: Guanethidine 3% and adrenaline 0.5%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Adrenaline 1%
Number of subjects: 0
Study: 30870087

Group type: EXPERIMENTAL
Intervention: Structural intervention refocusing government support programs for young women
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social network analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ego-centric and sociometric analyses
Number of subjects: 0
Study: 29783025

Group type: EXPERIMENTAL
Intervention: High-dose trivalent inactivated influenza vaccine (HDTIV)
Number of subjects: 47
Study: 28758311

Group type: EXPERIMENTAL
Intervention: Protected arm condition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Unprotected arm condition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Neutral arm condition
Number of subjects: 32

Group type: COMPARATOR
Intervention: Skin conductance level (SCL) measurements for all arm types
Number of subjects: 32
Study: 25027444

Group type: EXPERIMENTAL
Intervention: Alexander Technique lessons
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 23585346

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3
Number of subjects: 305

Group type: COMPARATOR
Intervention: 400 IU vitamin D3
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study: 21428726

Group type: EXPERIMENTAL
Intervention: fesoterodine 4 mg
Number of subjects: 1013

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1013
Study: 19695283

Group type: EXPERIMENTAL
Intervention: Maintenance-tailored therapy (MTT)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Standard behavior therapy (SBT)
Number of subjects: 213
Study: 16929238

Group type: EXPERIMENTAL
Intervention: Chilli diet (30 g/day of a chilli blend with 55% cayenne chilli)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chilli diet
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bland diet
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Glyceryl-trinitrate (GTN) and salbutamol
Number of subjects: 36
Study: 15502057

Group type: EXPERIMENTAL
Intervention: Mouth-to-bag resuscitator
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Automatic pressure-controlled ventilation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pediatric self-inflating bag ventilation
Number of subjects: 40
Study: 11255386

Group type: EXPERIMENTAL
Intervention: MBL-insufficient children (n=13)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Children aged 6 to 17 months (n=13)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Children aged 0 to 5 months
Number of subjects: 252

Group type: COMPARATOR
Intervention: Children aged 18 to 23 months
Number of subjects: 252
Study: 9631311

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg daily and amoxicillin 500 mg three times a day for 14 days (LA)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg daily and amoxicillin 500 mg three times a day for 14 days plus miconazole gel 100 mg three times a day for 14 days (LAM)
Number of subjects: 65
Study: 8153231

Group type: EXPERIMENTAL
Intervention: Heterosexually cued behaviors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Homosexually cued behaviors
Number of subjects: 0

Group type: COMPARATOR
Intervention: No cues
Number of subjects: 0
Study: 3244616

Group type: EXPERIMENTAL
Intervention: Heidelberg capsule (HC) ingestion after a standardized 500-kcal breakfast in males
Number of subjects: 36

Group type: COMPARATOR
Intervention: Heidelberg capsule (HC) ingestion in supine posture
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Heidelberg capsule (HC) ingestion in elderly males (greater than 65 years)
Number of subjects: 36
Study: 29204959

Group type: EXPERIMENTAL
Intervention: Alendronate for 10 years (Continuously treated group)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Alendronate for 5 years followed by a 5-year holiday (Discontinued group)
Number of subjects: 31
Study: 28969659

Group type: EXPERIMENTAL
Intervention: Azithromycin 20 mg/kg/day (maximum 1000 mg/day) in a single daily dose
Number of subjects: 330

Group type: COMPARATOR
Intervention: Co-trimoxazole 60 mg/kg/day (maximum 3000 mg/day) in two divided doses
Number of subjects: 330
Study: 26585952

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (1200 IU daily)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 24499609

Group type: EXPERIMENTAL
Intervention: SBIRT intervention for low or medium risk offenders, including brief intervention and referral to community treatment for high risk offenders.
Number of subjects: 800

Group type: COMPARATOR
Intervention: Minimal intervention for control group.
Number of subjects: 800
Study: 22031659

Group type: EXPERIMENTAL
Intervention: Low-dose plant-derived (n-3) fatty acids (2.2 g/d α-linolenic acid)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-dose plant-derived (n-3) fatty acids (6.6 g/d α-linolenic acid)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Low-dose marine-derived (n-3) fatty acids (1.2 g/d EPA and DHA)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-dose marine-derived (n-3) fatty acids (3.6 g/d EPA and DHA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-dose fish oil
Number of subjects: 100
Study: 18652090

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy followed by orthodontic expansion
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment followed by adenotonsillectomy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both therapies (adenotonsillectomy and orthodontic expansion)
Number of subjects: 32
Study: 16410460

Group type: EXPERIMENTAL
Intervention: rosiglitazone (4 mg BID)
Number of subjects: 24
Study: 12612145

Group type: EXPERIMENTAL
Intervention: Diet A (24 mg Met/(kg. d) and no Cys)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Diet B (13 mg Met/(kg. d) and 11 mg Cys/(kg. d))
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Diet C (5 mg Met/(kg. d) and 19 mg Cys/(kg. d))
Number of subjects: 5
Study: 10905679

Group type: EXPERIMENTAL
Intervention: Ceftriaxone antibiotic prophylaxis
Number of subjects: 224

Group type: COMPARATOR
Intervention: No prophylaxis (Control)
Number of subjects: 224
Study: 9143072

Group type: EXPERIMENTAL
Intervention: Melatonin 1 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Melatonin 40 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Melatonin (all doses)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 7973429

Group type: EXPERIMENTAL
Intervention: Intraluminal impedance measuring
Number of subjects: 20
Study: 2514318

Group type: EXPERIMENTAL
Intervention: rt‐PA (60 mg over 90 minutes i.v.)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 181193

Group type: EXPERIMENTAL
Intervention: Lithium carbonate, 0.3 gm every 8 hr
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 18
Study: 28350809

Group type: EXPERIMENTAL
Intervention: 12-session family-based intervention delivered to groups of families by lay facilitators
Number of subjects: 479
Study: 25790742

Group type: EXPERIMENTAL
Intervention: Plastic stents
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: uSEMS
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: pcSEMS
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: SEMS (uSEMS and pcSEMS)
Number of subjects: 219
Study: 21879354

Group type: EXPERIMENTAL
Intervention: Early go-signal for hand-related nouns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early go-signal for foot-related nouns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Early go-signal for left hand
Number of subjects: 0
Study: 21787499

Group type: EXPERIMENTAL
Intervention: RealSeal + gutta‐percha
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RealSeal + Resilon
Number of subjects: 40

Group type: COMPARATOR
Intervention: Exponential polymerization mode
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard polymerization mode
Number of subjects: 40
Study: 19405832

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (delayed treatment for 3 months)
Number of subjects: 22
Study: 17078435

Group type: EXPERIMENTAL
Intervention: Electrical acupuncture and auricular-plaster therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Oral hydrocortisone
Number of subjects: 64
Study: 15291662

Group type: EXPERIMENTAL
Intervention: Venlafaxine extended-release (XR)
Number of subjects: 1932

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1932

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR
Number of subjects: 1932
Study: 11207517

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg b.d. (OABC group)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Furazolidone 200 mg b.d. (OABF group)
Number of subjects: 118
Study: 8588060

Group type: EXPERIMENTAL
Intervention: Tryptophan/Large Neutral Amino Acids ratio
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tyrosine/Large Neutral Amino Acids ratio
Number of subjects: 0
Study: 1665116

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 7180724

Group type: EXPERIMENTAL
Intervention: Active diuretic therapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 30707731

Group type: EXPERIMENTAL
Intervention: Private time preference
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Social time preference
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Discounted utility model assumptions
Number of subjects: 650
Study: 28711115

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (CBT)
Number of subjects: 116
Study: 26458907

Group type: EXPERIMENTAL
Intervention: Oropharyngeal administration of mother's milk (0.2 mL every 2 hours for 48 hours, then every 3 hours until 32 weeks corrected-gestational age)
Number of subjects: 622

Group type: COMPARATOR
Intervention: Placebo (0.2 mL sterile water every 2 hours for 48 hours, then every 3 hours until 32 weeks corrected-gestational age)
Number of subjects: 622
Study: 23842828

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Primary iliac stent placement
Number of subjects: 112
Study: 21332400

Group type: EXPERIMENTAL
Intervention: STPG treatment (4 capsules, 2g)
Number of subjects: 14
Study: 19541291

Group type: EXPERIMENTAL
Intervention: Lutein, zeaxanthin and blackcurrant extract (LUT) supplement
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 18427455

Group type: EXPERIMENTAL
Intervention: Stalevo (levodopa/carbidopa/entacapone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 0
Study: 14740240

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg/day)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 11426007

Group type: EXPERIMENTAL
Intervention: Laser Doppler imaging
Number of subjects: 0

Group type: COMPARATOR
Intervention: Power Doppler sign
Number of subjects: 0
Study: 9608790

Group type: EXPERIMENTAL
Intervention: Bupivacaine + lidocaine (30 mg of bupivacaine plus 240 mg of lidocaine)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lidocaine (300 mg)
Number of subjects: 30
Study: 10048652

Group type: EXPERIMENTAL
Intervention: Children's hand cleanser
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Industrial hand cleansers
Number of subjects: 40

Group type: COMPARATOR
Intervention: Emollient
Number of subjects: 40
Study: 2695646

Group type: EXPERIMENTAL
Intervention: Light support pantyhose
Number of subjects: 0
Study: 831706

Group type: EXPERIMENTAL
Intervention: Acetazolamide plus staging
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 31838334

Group type: EXPERIMENTAL
Intervention: Community-Led Total Sanitation (CLTS)
Number of subjects: 3216

Group type: EXPERIMENTAL
Intervention: RANAS-based interventions
Number of subjects: 3216

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 3216
Study: 30234839

Group type: EXPERIMENTAL
Intervention: Inferior turbinate fracture combined with first probing
Number of subjects: 176

Group type: COMPARATOR
Intervention: Simple probing without inferior turbinate fracture
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Combined case and control groups (younger than 24 months)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Combined case and control groups (older than 24 months)
Number of subjects: 176
Study: 27541827

Group type: EXPERIMENTAL
Intervention: 6 monoclonal antibodies (SP142, E1L3N, 9A11, SP263, 22c3, and 28-8)
Number of subjects: 30
Study: 26437899

Group type: EXPERIMENTAL
Intervention: Essential amino acids (EAAs) 8 g/d
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isocaloric maltodextrin (placebo)
Number of subjects: 42
Study: 23452996

Group type: EXPERIMENTAL
Intervention: Narrow acquisition (NA)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Widened acquisition (WA)
Number of subjects: 205
Study: 20579849

Group type: EXPERIMENTAL
Intervention: Vitamin C 500 mg/d
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Vitamin C 100 mg/d
Number of subjects: 16
Study: 19425829

Group type: EXPERIMENTAL
Intervention: 6.0-microm droplets
Number of subjects: 15

Group type: COMPARATOR
Intervention: 4.0-microm droplets
Number of subjects: 15

Group type: COMPARATOR
Intervention: 5.0-microm droplets
Number of subjects: 15